Related references
Note: Only part of the references are listed.Eculizumab impairs Neisseria meningitidis serogroup B killing in whole blood despite 4CMenB vaccination of PNH patients
Jeroen D. Langereis et al.
BLOOD ADVANCES (2020)
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
Kioa Lente Wijnsma et al.
CLINICAL PHARMACOKINETICS (2019)
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update
Gianluigi Ardissino et al.
PEDIATRIC NEPHROLOGY (2018)
Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults
Monica Konar et al.
BLOOD (2017)
Share Paper
